News/ News/ Sales and Marketing Supernus bulks up its Parkinson’s portfolio with Adamas takeover Phil Taylor Adamas Pharmaceuticals, Flexion Therapeutics, M&A, Pacira, pain, Parkinson's disease, Supernus Pharma 0 Comment Supernus has boosted its position in central nervous system therapies with a $400 million deal to acquire Adamas Share X Supernus bulks up its Parkinson’s portfolio with Adamas takeover https://pharmaphorum.com/news/supernus-bulks-up-its-parkinsons-portfolio-with-adamas-takeover/